Annual Total Assets
$123.65 M
+$102.56 M+486.34%
31 March 2024
Summary:
VistaGen Therapeutics annual total assets is currently $123.65 million, with the most recent change of +$102.56 million (+486.34%) on 31 March 2024. During the last 3 years, it has risen by +$15.37 million (+14.20%). VTGN annual total assets is now at all-time high.VTGN Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$102.50 M
-$11.05 M-9.73%
30 September 2024
Summary:
VistaGen Therapeutics quarterly total assets is currently $102.50 million, with the most recent change of -$11.05 million (-9.73%) on 30 September 2024. Over the past year, it has increased by +$60.30 million (+142.91%). VTGN quarterly total assets is now -21.80% below its all-time high of $131.07 million, reached on 31 December 2023.VTGN Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTGN Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +486.3% | +142.9% |
| 3 y3 years | +14.2% | +2.0% |
| 5 y5 years | +782.5% | +1073.3% |
VTGN Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +486.3% | -21.8% | +581.8% |
| 5 y | 5 years | at high | +2042.2% | -21.8% | +1822.7% |
| alltime | all time | at high | >+9999.0% | -21.8% | >+9999.0% |
VistaGen Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $102.50 M(-9.7%) |
| June 2024 | - | $113.55 M(-8.2%) |
| Mar 2024 | $123.65 M(+486.3%) | $123.65 M(-5.7%) |
| Dec 2023 | - | $131.07 M(+210.6%) |
| Sept 2023 | - | $42.20 M(+180.7%) |
| June 2023 | - | $15.03 M(-28.7%) |
| Mar 2023 | $21.09 M(-71.7%) | $21.09 M(-29.0%) |
| Dec 2022 | - | $29.71 M(-27.0%) |
| Sept 2022 | - | $40.70 M(-30.7%) |
| June 2022 | - | $58.73 M(-21.3%) |
| Mar 2022 | $74.64 M(-31.1%) | $74.64 M(-17.6%) |
| Dec 2021 | - | $90.54 M(-9.9%) |
| Sept 2021 | - | $100.50 M(-3.3%) |
| June 2021 | - | $103.91 M(-4.0%) |
| Mar 2021 | $108.28 M(+1775.9%) | $108.28 M(-0.9%) |
| Dec 2020 | - | $109.27 M(+439.1%) |
| Sept 2020 | - | $20.27 M(+228.7%) |
| June 2020 | - | $6.17 M(+6.8%) |
| Mar 2020 | $5.77 M(-58.8%) | $5.77 M(+8.3%) |
| Dec 2019 | - | $5.33 M(-39.0%) |
| Sept 2019 | - | $8.74 M(-32.5%) |
| June 2019 | - | $12.95 M(-7.6%) |
| Mar 2019 | $14.01 M(+24.2%) | $14.01 M(+86.3%) |
| Dec 2018 | - | $7.52 M(-15.4%) |
| Sept 2018 | - | $8.89 M(+7.7%) |
| June 2018 | - | $8.26 M(-26.8%) |
| Mar 2018 | $11.28 M(+203.8%) | $11.28 M(-20.8%) |
| Dec 2017 | - | $14.24 M(+444.1%) |
| Sept 2017 | - | $2.62 M(+7.4%) |
| June 2017 | - | $2.44 M(-34.4%) |
| Mar 2017 | $3.71 M | $3.71 M(-36.8%) |
| Dec 2016 | - | $5.88 M(-16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | - | $7.02 M(-19.8%) |
| June 2016 | - | $8.76 M(+784.8%) |
| Mar 2016 | $989.80 K(+267.0%) | $989.80 K(-50.8%) |
| Dec 2015 | - | $2.01 M(+4.1%) |
| Sept 2015 | - | $1.93 M(+10.8%) |
| June 2015 | - | $1.74 M(+546.6%) |
| Mar 2015 | $269.70 K(+2.3%) | $269.70 K(+4.0%) |
| Dec 2014 | - | $259.40 K(-33.0%) |
| Sept 2014 | - | $386.90 K(-49.4%) |
| June 2014 | - | $764.70 K(+190.0%) |
| Mar 2014 | $263.70 K(-70.1%) | $263.70 K(-19.8%) |
| Dec 2013 | - | $328.90 K(-19.0%) |
| Sept 2013 | - | $406.00 K(-6.0%) |
| June 2013 | - | $431.80 K(-51.0%) |
| Mar 2013 | $881.50 K(+158.1%) | $881.50 K(+170.4%) |
| Dec 2012 | - | $326.00 K(-23.2%) |
| Sept 2012 | - | $424.60 K(-34.2%) |
| June 2012 | - | $645.00 K(+88.8%) |
| Mar 2012 | $341.60 K(>+9900.0%) | $341.60 K(-14.5%) |
| Dec 2011 | - | $399.70 K(-25.6%) |
| Sept 2011 | - | $537.30 K(-68.1%) |
| June 2011 | - | $1.68 M(>+9900.0%) |
| Mar 2011 | - | $6400.00(+190.9%) |
| Dec 2010 | $2200.00(+57.1%) | $2200.00(-21.4%) |
| Sept 2010 | - | $2800.00(+12.0%) |
| June 2010 | - | $2500.00(-41.9%) |
| Mar 2010 | - | $4300.00(+207.1%) |
| Dec 2009 | $1400.00(-93.9%) | $1400.00(-65.0%) |
| Sept 2009 | - | $4000.00(+53.8%) |
| June 2009 | - | $2600.00(-88.7%) |
| Dec 2008 | $23.10 K | $23.10 K(>+9900.0%) |
| June 2008 | - | $200.00(-33.3%) |
| Mar 2008 | - | $300.00 |
FAQ
- What is VistaGen Therapeutics annual total assets?
- What is the all time high annual total assets for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual total assets year-on-year change?
- What is VistaGen Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly total assets year-on-year change?
What is VistaGen Therapeutics annual total assets?
The current annual total assets of VTGN is $123.65 M
What is the all time high annual total assets for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual total assets is $123.65 M
What is VistaGen Therapeutics annual total assets year-on-year change?
Over the past year, VTGN annual total assets has changed by +$102.56 M (+486.34%)
What is VistaGen Therapeutics quarterly total assets?
The current quarterly total assets of VTGN is $102.50 M
What is the all time high quarterly total assets for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly total assets is $131.07 M
What is VistaGen Therapeutics quarterly total assets year-on-year change?
Over the past year, VTGN quarterly total assets has changed by +$60.30 M (+142.91%)